Article
HLA-based banking of induced pluripotent stem cells in Saudi Arabia
18 Dec 2023
Abstract excerpt
BACKGROUND: Human iPSCs' derivation and use in clinical studies are transforming medicine. Yet, there is a high cost and long waiting time associated with autologous iPS-based cellular therapy, and the genetic engineering of hypo-immunogenic iPS cell lines is hampered with numerous hurdles. Therefore, it is increasingly interesting to create cell stocks based on HLA haplotype distribution in a given population....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
